ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 205 filers reported holding ISIS PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 1.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $5,571,000 | -15.8% | 90,238 | -47.1% | 0.01% | -17.6% |
| Q3 2014 | $6,619,000 | -75.8% | 170,459 | -78.6% | 0.02% | -45.2% |
| Q2 2014 | $27,388,000 | +644.8% | 795,370 | +834.7% | 0.03% | +287.5% |
| Q1 2014 | $3,677,000 | -93.2% | 85,098 | -93.7% | 0.01% | -93.4% |
| Q4 2013 | $54,231,000 | -18.8% | 1,361,230 | -23.5% | 0.12% | -21.4% |
| Q3 2013 | $66,807,000 | +17.9% | 1,779,609 | -15.6% | 0.15% | +17.6% |
| Q2 2013 | $56,649,000 | – | 2,108,266 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 7,202,585 | $270,385,000 | 14.71% |
| DOWLING & YAHNKE LLC | 675,798 | $25,369,000 | 3.98% |
| GARRISON BRADFORD & ASSOCIATES INC | 100,700 | $3,780,000 | 3.87% |
| WILLIAM HARRIS INVESTORS INC | 312,834 | $11,743,000 | 3.67% |
| Meditor Group Ltd | 490,000 | $18,395,000 | 2.59% |
| AVALON CAPITAL MANAGEMENT | 50,943 | $1,912,000 | 1.89% |
| Orinda Asset Management LLC | 14,665 | $551,000 | 1.73% |
| PINNACLE ASSOCIATES LTD | 2,064,760 | $77,511,000 | 1.60% |
| PERKINS CAPITAL MANAGEMENT INC | 52,850 | $1,984,000 | 1.43% |
| NCM Capital Advisers, Inc. | 24,950 | $937,000 | 1.04% |